CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2012	Sep. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net income	$ 30,270	$ 81,259
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred tax benefit	(11,354)	(4,938)
Depreciation and amortization	15,051	12,925
Amortization of programming rights	220,187	209,047
Amortization of sublicensing rights and own production cost	4,304	1,796
Stock based compensation expense	5,352	15,592
Equity in income of unconsolidated investees	(657)	(514)
Foreign currency losses/(gains)	(1,666)	307
Impairment loss	82,503	16,843
Changes in operating assets and liabilities:
Trade accounts receivable	(13,024)	10,242
Prepayments	(3,594)	(8,727)
Other assets	(11,270)	(4,338)
Accounts payable and accrued liabilities	14,150	(5,188)
Deferred revenue	5,994	(1,026)
Other liabilities	(7,600)	(12,860)
Dividends received from equity investees	485	533
Acquisition of programming and sublicensing rights	(272,158)	(253,960)
Net cash provided by operating activities	56,973	56,993
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions of property and equipment and intangible assets	(9,437)	(16,037)
Acquisitions of businesses, net of cash acquired	(2,683)	(24,476)
Receipts from deposits	39,014	38,646
Net cash provided by (used in) investing activities	26,894	(1,867)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options	4,615	5,352
Settlement of overdraft	(10,756)
Dividends paid to stockholders	(61,683)	(59,714)
Dividends paid to noncontrolling interest	(4,195)	(4,813)
Net cash used in financing activities	(72,019)	(59,175)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(178)	1,332
Net increase/(decrease) in cash and cash equivalents	11,670	(2,717)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	12,331	59,565
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 24,001	$ 56,848